Exhibits and Financial Statement Schedules 61 Item 16. The forward-looking statements in this Report on Form 10-K do not constitute guarantees of future performance. Investors are cautioned that statements in this Report on Form 10-K which are not strictly historical statements, including, without limitation, express or implied statements or guidance regarding current or future financial performance and position, management ’ s strategy, plans and objectives for future operations or acquisitions, product development and sales, product research and development, regulatory approvals, selling, general and administrative expenditures, intellectual property, development and manufacturing plans, availability of materials and products, the direct and indirect effects of tariffs and uncertainty regarding tariff policies, adequacy of capital resources and financing plans constitute forward-looking statements, competitive factors, tax rates and cost savings.

Exhibits and Financial Statement Schedules 75 Item 16. The forward-looking statements in this annual report do not constitute guarantees of future performance. Investors are cautioned that statements in this annual report which are not strictly historical statements, including, without limitation, express or implied statements or guidance regarding current or future financial performance and position, management ’ s strategy, plans and objectives for future operations or acquisitions, product development and sales, product research and development, regulatory approvals, selling, general and administrative expenditures, intellectual property, development and manufacturing plans, availability of materials and products, the direct and indirect effects of tariffs and uncertainty regarding tariff policies, adequacy of capital resources and financing plans constitute forward-looking statements, competitive factors, tax rates and cost savings.

The forward-looking statements in this Report on Form 10-K do not constitute guarantees of future performance. Investors are cautioned that statements in this Report on Form 10-K which are not strictly historical statements, including, without limitation, express or implied statements or guidance regarding current or future financial performance and position, management ’ s strategy, plans and objectives for future operations or acquisitions, product development and sales, product research and development, regulatory approvals, selling, general and administrative expenditures, intellectual property, development and manufacturing plans, availability of materials and products, the direct and indirect effects of tariffs and uncertainty regarding tariff policies, adequacy of capital resources and financing plans constitute forward-looking statements, competitive factors, tax rates and cost savings. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which the Company operates, and…

The forward-looking statements in this annual report do not constitute guarantees of future performance. Investors are cautioned that statements in this annual report which are not strictly historical statements, including, without limitation, express or implied statements or guidance regarding current or future financial performance and position, management ’ s strategy, plans and objectives for future operations or acquisitions, product development and sales, product research and development, regulatory approvals, selling, general and administrative expenditures, intellectual property, development and manufacturing plans, availability of materials and products, the direct and indirect effects of tariffs and uncertainty regarding tariff policies, adequacy of capital resources and financing plans constitute forward-looking statements, competitive factors, tax rates and cost savings. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which the Company operates, and management ’ s current beliefs and assumptions.

Business In this Annual Report on Form 10-K, Mesa Laboratories, Inc., a Colorado corporation, together with its subsidiaries is collectively referred to as “we,” “us,” “our,” the “Company,” or "Mesa." Mesa was organized in 1982 as a Colorado corporation. General We are a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries.

Business In this annual report, Mesa Laboratories, Inc., a Colorado corporation, together with its subsidiaries is collectively referred to as “we,” “us,” “our,” the “Company,” or “Mesa.” Mesa was organized in 1982 as a Colorado corporation. General We are a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTES OF OPERATIONS Overview KB Global Holdings Limited (“Company”) is a Cayman Islands limited company. Its subsidiary, the WFOE, has a contractual right to control the operations of BKJZ in the PRC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Overview KB Global Holdings Limited (“Company”) is a Cayman Islands limited company. Its subsidiary, the WFOE, has a contractual right to control the operations of BKJZ in the PRC.

1,301 1,301 – 0.00 Additional paid-in capital 96,999 96,999 – 0.00 Accumulated deficit (366,416 ) (292,195 ) (74,221 ) 25.40 Accumulated other comprehensive loss (2,538 ) (1,188 ) (1,350 ) 113.64 Total shareholders’ deficit (270,654 ) (195,083 ) (75,571 ) 38.74 Total liabilities and shareholders’ equity $ 50,317 $ 416,325 $ (366,008 ) (87.91 ) 8 Advance from Customer: In the fall of 2023, $145,800 was recorded as a deposit from Beijing Kabeilongteng Investment Center (Limited partnership) for the development of a software system by BJKZ. The software system was delivered during the first quarter of 2024, and the deposit was reclassified as operating income of the Company. For the Years Ended December 31, Changes in 2024 2023 Amount Percentage Advance from customer $ – $ 145,800 $ (145,800 ) N/A Shareholders’ Equity : In January and February 2023, the…

Our strategic vision is anchored in leveraging our existing strengths to achieve sustainable growth and innovation in our operations. The Company generated its first revenue in 2024 and completed a full software delivery cycle. While 2025 was a transition year with no revenue, management views this period as strategic preparation for scaling customer acquisition.

Risk Factors As A Smaller Reporting Company, We Are Not Required To Provide A Statement Of Risk Factors.

RISK FACTORS As a smaller reporting company, we are not required to provide a comprehensive statement of risk factors. However, the following concise summary is provided for investor transparency: The Company is an early-stage enterprise software company with limited revenue history.

Fiscal year ended February 28, 2025 compared to the fiscal year ended February 29, 2024 Revenue We did not recognize any revenue for the years ended February 28, 2025 and February 29, 2024. Operating Expenses General and administrative expenses were $203,734 for the year ended February 28, 2025, compared to $199,426 for the year ended February 29, 2024, an increase of only $4,308 or 2.2%. In the current year, we incurred $144,000 of expense from our service agreement with Anvi Global Inc. (previously with Strategic-IT Group Inc) (Note 4), professional fees of $35,792, OTC fees of $15,700, transfer agent fees of $1,300 and other general expenses of $6,942.

Fiscal year ended February 28, 2026 compared to the fiscal year ended February 28, 2025 Revenue We did not recognize any revenue for the years ended February 28, 2026 and 2025. Operating Expenses General and administrative expenses were $196,933 for the year ended February 28, 2026, compared to $203,734 for the year ended February 28, 2025, a decrease of only $6,801 or 3.3%. In the current year, we incurred $144,000 of expenses from our service agreement with Anvi Global Inc. (Note 5), professional fees of $25,419, OTC fees of $17,445, transfer agent fees of $1,200 and other general expenses of $8,869.

Operating Expenses General and administrative expenses were $203,734 for the year ended February 28, 2025, compared to $199,426 for the year ended February 29, 2024, an increase of only $4,308 or 2.2%. In the current year, we incurred $144,000 of expense from our service agreement with Anvi Global Inc. (previously with Strategic-IT Group Inc) (Note 4), professional fees of $35,792, OTC fees of $15,700, transfer agent fees of $1,300 and other general expenses of $6,942. In the prior period, we incurred $144,000 of expense from our service agreement with Strategic-IT Group Inc, professional fees of $27,614, travel expense of $769, OTC fees of $15,100, transfer agent fees of $1,100 and other general expenses of $10,843.

Operating Expenses General and administrative expenses were $196,933 for the year ended February 28, 2026, compared to $203,734 for the year ended February 28, 2025, a decrease of only $6,801 or 3.3%. In the current year, we incurred $144,000 of expenses from our service agreement with Anvi Global Inc. (Note 5), professional fees of $25,419, OTC fees of $17,445, transfer agent fees of $1,200 and other general expenses of $8,869. In the prior period, we incurred $144,000 of expense from our service agreement with Anvi Global Inc., professional fees of $35,792, OTC fees of $15,700, transfer agent fees of $1,300 and other general expenses of $6,942.